Publicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (22)

2022

  1. Case Report: Pharmacogenetics Applied to Precision Psychiatry Could Explain the Outcome of a Patient With a New CYP2D6 Genotype

    Frontiers in Psychiatry, Vol. 12

  2. Ten Years of Experience Support Pharmacogenetic Testing to Guide Individualized Drug Therapy

    Pharmaceutics, Vol. 14, Núm. 1

2021

  1. Economic impact of the application of a precision medicine model (5SPM) on psychotic patients

    Pharmacogenomics and Personalized Medicine, Vol. 14, pp. 1015-1025

2018

  1. Usefulness of pharmacogenetic analysis in psychiatric clinical practice: A case report

    Clinical Psychopharmacology and Neuroscience, Vol. 16, Núm. 3, pp. 349-357

2017

  1. Pharmacogenetics and the treatment of asthma

    Pharmacogenomics, Vol. 18, Núm. 13, pp. 1271-1280

2016

  1. A systematic in silico approach

    Methods in Molecular Biology (Humana Press Inc.), pp. 15-27

  2. Impact of new technologies on pharmacogenomics

    Current Pharmacogenomics and Personalized Medicine, Vol. 14, Núm. 2, pp. 74-85

  3. Pharmacogenetics to prevent maniac affective switching with treatment for bipolar disorder: CYP2D6

    Pharmacogenomics, Vol. 17, Núm. 12, pp. 1291-1293

  4. Role of Pharmacogenetics in Improving the Safety of Psychiatric Care by Predicting the Potential Risks of Mania in CYP2D6 Poor Metabolizers Diagnosed with Bipolar Disorder

    Medicine (United States), Vol. 95, Núm. 6

2015

  1. Primun non nocere, polypharmacy and pharmacogenetics

    Pharmacogenomics

2014

  1. Characterization of a complex CYP2D6 genotype that caused an AmpliChip CYP450 Test® no-call in the clinical setting

    Clinical Chemistry and Laboratory Medicine, Vol. 52, Núm. 6, pp. 799-807

  2. Dose reduction of efavirenz: An observational study describing cost-effectiveness, pharmacokinetics and pharmacogenetics

    Pharmacogenomics, Vol. 15, Núm. 7, pp. 997-1006

2012

  1. Modulation of the serum cytokine expression pattern in hymenoptera allergic patients treated with specific venom immunotherapy

    Open Immunology Journal, Vol. 5, Núm. 1, pp. 13-19

2005

  1. Anti-cyclic citrullinated peptide autoantibodies in IgM rheumatoid factor-positive patients

    Clinica Chimica Acta, Vol. 354, Núm. 1-2, pp. 123-130

  2. Clinical evaluation of a microsphere bead-based flow cytometry assay for the simultaneous determination of anti-thyroid peroxidase and anti-thyroglobulin antibodies

    Clinical Biochemistry, Vol. 38, Núm. 11, pp. 966-972

  3. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients

    Clinica Chimica Acta, Vol. 359, Núm. 1-2, pp. 109-114

2004

  1. Anti-nucleosome, anti-chromatin, anti-dsDNA and anti-histone antibody reactivity in systemic lupus erythematosus

    Clinical Chemistry and Laboratory Medicine, Vol. 42, Núm. 3, pp. 266-272

  2. Clinical Evaluation of Cobas Core Anti-dsDNA EIA Quant

    Journal of Clinical Laboratory Analysis, Vol. 18, Núm. 3, pp. 200-205

  3. Partial Androgen Deficiency in Aging Type 2 Diabetic Men and Its Relationship to Glycemic Control

    Metabolism: Clinical and Experimental, Vol. 53, Núm. 5, pp. 666-672

2001

  1. Estudio del gen HFE en una familia Española con hemocromatosis hereditaria

    Medicina Clinica, Vol. 116, Núm. 3, pp. 100-103